Hitesh Harsukhbhai Chandpa

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (14)

• Engineering virus-like particles for lymph-node targeted cancer immunotherapy: strategies, challenges, and future prospects
  Drug Discovery Today 2026 DOI: 10.1016/j.drudis.2026.104647
  +Save
• Design of a cholic acid-based triarmed star polymer network for targeted and sustained drug delivery for melanoma treatment
  Journal of Materials Chemistry B 2026 DOI: 10.1039/d6tb00166a
  +Save
• Doxorubicin Intercalated Co‐Al Layered Double Hydroxide Nanocarrier With pH‐Responsive Controlled Release and Selective Melanoma Suppression: Toward Next‐Generation Nanotherapeutics
  Small 2025 DOI: 10.1002/smll.202506499
  +Save
• Clinical Validations of Localized Cancer Nanomedicine
  Advancements in Cancer Theranostics 2025 DOI: 10.1007/978-981-95-0938-6_7
  +Save
• Nanoparticles engineering strategies for lymph-node targeted cancer immunotherapy
  Nano Trends 2025 DOI: 10.1016/j.nwnano.2025.100128
  +Save
• Effect of Stress-WIN, a novel polyherbal formulation, on DOCA-salt-induced hypertensive Wistar rats
  Discover Applied Sciences 2025 DOI: 10.1007/s42452-025-07420-4
  +Save
• Mechanically Responsive Organic–Inorganic Hybrid as Advanced Delivery Vehicle for Targeted Cancer Treatment
  Advanced Healthcare Materials 2025 DOI: 10.1002/adhm.202500738
  +Save
• Computer Integrated Dominant Epitopes Evoke Protective Immune Response Against Streptococcus pneumoniae
  Immunology 2025 DOI: 10.1111/imm.13920
  +Save
• LC-HRMS metabolomics, isolation, network pharmacology, and molecular docking based evaluation of anti-cancer potential of compounds of Glycyrrhiza glabra L.
  Pharmacological Research - Natural Products 2025 DOI: 10.1016/j.prenap.2025.100271
  +Save
• Dominant B cell-T cell epitopes instigated robust immune response in-silico against Scrub Typhus
  Vaccine 2024 DOI: 10.1016/j.vaccine.2024.04.082
  +Save